EBERHARD ROY SAMLOWSKI, MD

DALLAS, TX

Research Active
Family Medicine NPI registered 21+ years 2 publications 2019 – 2022 NPI: 1679579312
Family Medicine Surgery
COVID-19Postoperative ComplicationsQuality ImprovementPandemicsReoperation

Practice Location

17218 PRESTON RD STE 2000
DALLAS, TX 75252-4018

Phone: (877) 866-7123

What does EBERHARD SAMLOWSKI research?

Dr. Samlowski studies the impact of the COVID-19 pandemic on surgical practices, specifically looking at how the number of surgeries declined and how complications increased during this time. He also focuses on innovative surgical techniques, such as Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA), which is used to control severe internal bleeding, particularly in patients with conditions like pancreatic cancer. His research aims to improve patient outcomes during critical situations by evaluating both systemic impacts on surgery and novel emergency interventions.

Key findings

  • In 2020, there was a 27% decrease in surgeries compared to 2019, particularly notable in the second quarter of the year.
  • Post-operative complications rose to 13%, the highest level since 2015, during the peak of the pandemic.
  • REBOA was successfully used to stabilize a patient with catastrophic bleeding from the gastroduodenal artery after a Whipple procedure, highlighting its effectiveness in emergencies when other methods failed.

Frequently asked questions

Does Dr. Samlowski study surgery during the COVID-19 pandemic?
Yes, he examines how the pandemic affected the volume of surgeries and associated complications.
What innovative treatments has Dr. Samlowski researched?
He has researched the use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for managing severe internal bleeding.
Is Dr. Samlowski's work relevant to patients experiencing surgical complications?
Yes, his research provides critical insights that can help patients understand the risks and management strategies for complications.

Publications in plain English

Characterizing the volume of surgery and post-operative complications during the COVID-19 pandemic.

2022

Langenbeck's archives of surgery

Moss WD, Pires GR, Samlowski E, Webb J, DeAngelo MM +4 more

Plain English
This study examined how the COVID-19 pandemic affected the number of surgeries and the complications that followed. In 2020, there was a significant drop in surgeries, especially in the second quarter (April to June), where there was a nearly 27% decrease compared to 2019. During this time, patients faced higher complications, with around 13% experiencing problems—this was the highest level of complications since 2015, though the situation improved later in the year. Who this helps: This research benefits patients undergoing surgery, as it provides insights into how the pandemic impacted surgical care.

PubMed

Catastrophic Bleeding From Gastroduodenal Artery After Whipple Procedure Managed With Resuscitative Endovascular Balloon Occlusion of the Aorta.

2019

ACG case reports journal

Samlowski E, Okwuosa C, Tashjian N, Wagner M

Plain English
This study looked at using a procedure called Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) to manage severe internal bleeding in a man with pancreatic cancer who had a complication after surgery. After traditional methods failed to stop the bleeding, REBOA successfully stabilized his condition until he could undergo more definitive surgery. This finding is important because it shows that REBOA can be a lifesaving option for patients experiencing massive gastrointestinal bleeding when other treatments don’t work. Who this helps: This helps patients with severe gastrointestinal bleeding.

PubMed

Frequent Co-Authors

Whitney D Moss Giovanna R Pires Justin Webb Madeline M DeAngelo Devin Eddington Ben J Brintz Jayant Agarwal Alvin C Kwok Chris Okwuosa Nara Tashjian

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.